194 related articles for article (PubMed ID: 33600879)
1. Ultrasound-sensitive nanodroplets achieve targeted neuromodulation.
Lea-Banks H; Meng Y; Wu SK; Belhadjhamida R; Hamani C; Hynynen K
J Control Release; 2021 Apr; 332():30-39. PubMed ID: 33600879
[TBL] [Abstract][Full Text] [Related]
2. Localized anesthesia of a specific brain region using ultrasound-responsive barbiturate nanodroplets.
Lea-Banks H; O'Reilly MA; Hamani C; Hynynen K
Theranostics; 2020; 10(6):2849-2858. PubMed ID: 32194839
[No Abstract] [Full Text] [Related]
3. Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.
Chen CC; Sheeran PS; Wu SY; Olumolade OO; Dayton PA; Konofagou EE
J Control Release; 2013 Dec; 172(3):795-804. PubMed ID: 24096019
[TBL] [Abstract][Full Text] [Related]
4. Sub-millimetre precision of drug delivery in the brain from ultrasound-triggered nanodroplets.
Lea-Banks H; Hynynen K
J Control Release; 2021 Oct; 338():731-741. PubMed ID: 34530050
[TBL] [Abstract][Full Text] [Related]
5. Physical Characterization to Improve Scalability and Potential of Anesthetic-Loaded Nanodroplets.
Ting SG; Lea-Banks H; Hynynen K
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631291
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-triggered oxygen-loaded nanodroplets enhance and monitor cerebral damage from sonodynamic therapy.
Lea-Banks H; Wu SK; Lee H; Hynynen K
Nanotheranostics; 2022; 6(4):376-387. PubMed ID: 35795341
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound triggered phase-change nanodroplets for doxorubicin prodrug delivery and ultrasound diagnosis: An in vitro study.
Gao J; Yu B; Li C; Xu M; Cao Z; Xie X; Wang W; Liu J
Colloids Surf B Biointerfaces; 2019 Feb; 174():416-425. PubMed ID: 30481702
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
9. Drug Release from Phase-Changeable Nanodroplets Triggered by Low-Intensity Focused Ultrasound.
Cao Y; Chen Y; Yu T; Guo Y; Liu F; Yao Y; Li P; Wang D; Wang Z; Chen Y; Ran H
Theranostics; 2018; 8(5):1327-1339. PubMed ID: 29507623
[No Abstract] [Full Text] [Related]
10. Ultrasound-assisted investigation of photon triggered vaporization of poly(vinylalcohol) phase-change nanodroplets: A preliminary concept study with dosimetry perspective.
Toumia Y; Miceli R; Domenici F; Heymans SV; Carlier B; Cociorb M; Oddo L; Rossi P; D'Angellilo RM; Sterpin E; D'Agostino E; Van Den Abeele K; D'hooge J; Paradossi G
Phys Med; 2021 Sep; 89():232-242. PubMed ID: 34425514
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Sonothrombolysis in Aged Clots between Low-Boiling-Point Phase-Change Nanodroplets and Microbubbles of the Same Composition.
Kim J; DeRuiter RM; Goel L; Xu Z; Jiang X; Dayton PA
Ultrasound Med Biol; 2020 Nov; 46(11):3059-3068. PubMed ID: 32800631
[TBL] [Abstract][Full Text] [Related]
12. Neuromodulation accompanying focused ultrasound-induced blood-brain barrier opening.
Chu PC; Liu HL; Lai HY; Lin CY; Tsai HC; Pei YC
Sci Rep; 2015 Oct; 5():15477. PubMed ID: 26490653
[TBL] [Abstract][Full Text] [Related]
13. Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery.
Wu SY; Fix SM; Arena CB; Chen CC; Zheng W; Olumolade OO; Papadopoulou V; Novell A; Dayton PA; Konofagou EE
Phys Med Biol; 2018 Jan; 63(3):035002. PubMed ID: 29260735
[TBL] [Abstract][Full Text] [Related]
14. Camptothecin-loaded fusogenic nanodroplets as ultrasound theranostic agent in stem cell-mediated drug-delivery system.
Ho YJ; Chiang YJ; Kang ST; Fan CH; Yeh CK
J Control Release; 2018 May; 278():100-109. PubMed ID: 29630986
[TBL] [Abstract][Full Text] [Related]
15. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
16. Submicron-bubble-enhanced focused ultrasound for blood-brain barrier disruption and improved CNS drug delivery.
Fan CH; Liu HL; Ting CY; Lee YH; Huang CY; Ma YJ; Wei KC; Yen TC; Yeh CK
PLoS One; 2014; 9(5):e96327. PubMed ID: 24788566
[TBL] [Abstract][Full Text] [Related]
17. Modulating ultrasound contrast generation from injectable nanodroplets for proton range verification by varying the degree of superheat.
Heymans SV; Carlier B; Toumia Y; Nooijens S; Ingram M; Giammanco A; d'Agostino E; Crijns W; Bertrand A; Paradossi G; Himmelreich U; D'hooge J; Sterpin E; Van Den Abeele K
Med Phys; 2021 Apr; 48(4):1983-1995. PubMed ID: 33587754
[TBL] [Abstract][Full Text] [Related]
18. Plasmid-loadable magnetic/ultrasound-responsive nanodroplets with a SPIO-NP dispersed perfluoropentane core and lipid shell for tumor-targeted intracellular plasmid delivery.
Dong W; Huang A; Huang J; Wu P; Guo S; Liu H; Qin M; Yang X; Zhang B; Wan M; Zong Y
Biomater Sci; 2020 Oct; 8(19):5329-5345. PubMed ID: 32793943
[TBL] [Abstract][Full Text] [Related]
19. PEGylated PLGA-based phase shift nanodroplets combined with focused ultrasound for blood brain barrier opening in rats.
Zhang X; Hu J; Zhao G; Huang N; Tan Y; Pi L; Huang Q; Wang F; Wang Z; Wang Z; Cheng Y
Oncotarget; 2017 Jun; 8(24):38927-38936. PubMed ID: 28473660
[TBL] [Abstract][Full Text] [Related]
20. Preparation of novel curcumin-loaded multifunctional nanodroplets for combining ultrasonic development and targeted chemotherapy.
Ji G; Yang J; Chen J
Int J Pharm; 2014 May; 466(1-2):314-20. PubMed ID: 24657138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
